Peptide Therapy
LQV Branded Vial
Retatrutide
Peptide Therapy
Retatrutide
From $449|
Provider Approved
Rx RequiredRetatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors. By engaging three metabolic pathways, it represents the next generation of weight management therapies with the potential for greater efficacy in both weight loss and metabolic improvement.
Key Benefits
Triple-receptor targeting for comprehensive metabolic impact
Increased energy expenditure through glucagon activation
Enhanced fat oxidation and breakdown
Robust appetite suppression
Potential for greater total body weight reduction
1
Total$449.00
Medically directedShips nationwide
Prescription therapies require medical evaluation and supervision. Results vary. Side effects and risks are discussed during consultation.